Huanuokang Aims to Surpass Global Competitors in High-End Endoscopy with Seven Key Advantages and Self-Developed Breakthroughs Within Three Years
The Political Bureau of the CPC Central CommitteeA meeting was held on August 26, 2016, to review and approve《"Healthy China 2030" Planning Outline》。“The Outline” points out that promoting health technology innovation is one of the important breakthroughs in advancing the construction of a Healthy China. It calls for achieving breakthroughs in key technologies such as precision medicine and smart healthcare, prioritizing the localization of medical devices, and significantly enhancing the scientific and technological support capabilities for the prevention and treatment of major diseases and the development of the health industry.
Guided by the overarching goals of supporting the Healthy China initiative and promoting the localization of medical devices, Zhejiang Healnoc Technology Co., Ltd. was established in Hangzhou, Zhejiang Province, on October 11, 2018. Healnoc is a high-tech enterprise dedicated to the research and development, manufacturing, sales, and service of high-end medical devices. Located by the Qiantang River and harnessing its regional strength, the company leverages advanced imaging technologies combined with extensive clinical experience to provide the healthcare industry with cutting-edge, visionary, and high-level medical solutions.
Healnoc has assembled a team of senior experts covering the full product lifecycle—from hardware and software to algorithms—and boasts a cohort of highly skilled technical and management professionals with extensive practical experience. The company commands core technologies in optics, mechanics, electronics, and algorithms, achieving world-leading proficiency in embedded system development, advanced image and video processing, and intelligent algorithms.
The company adheres to the strategy of integrating “industry,” “academia,” and “research,” engaging in deep collaboration with renowned institutions such as Zhejiang University and Sir Run Run Shaw Hospital, as well as Grade 3A hospitals, to drive a new future for the high-end endoscopy industry.
In 2018, driven by Mr. Fu Liquan, Chairman of Dahua Technology, in his commitment to developing domestically produced medical devices and building a nationally respected brand within China’s medical device industry, Healnoc embarked on its journey into the healthcare sector.
Healnoc, though a young company,However, researchers account for more than 50% of the team members., supporting Healnoc’s product R&D. As a strategic investment by Zhejiang Dahua Technology in the medical sector, Healnoc has leveraged its long-term technical expertise in video imaging and algorithms to establish competitive advantages in endoscope R&D from its inception, achieving significant results.
The core product, the 4K UHD endoscopic camera system module, integrates advanced endoscopy, optical technology, and digital imaging techniques to deliver superior image clarity. It effectively assists physicians in performing high-precision surgical procedures, demonstrating significant clinical application value.。
October 11, 2019,He Chao, Former President of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Appointed Chairman of Healnoc, responsible for providing overall strategic guidance to the company. With a focus on clinical needs, we further collaborate with internationally leading medical device companies and engage in deep partnerships with renowned domestic universities and Grade A tertiary hospitals, delivering healthcare solutions that integrate digitalization, the Internet of Things (IoT), and artificial intelligence technologies for the medical industry.
Additionally, Healnoc’s independently developed endoscopy system has obtained CF-level safety certification. The company is capable of independently researching and developing adaptive image algorithms tailored to minimally invasive surgical scenarios, achieving full approval in its initial product registration in just 10 months.
The origins of endoscopy can be traced back to the 19th century. In 1795, Philipp Bozzini of Germany pioneered the endoscope. Since 1835, when Antoine Jean Desormeaux, known as the "father of endoscopy," used candlelight as a light source and a thin iron tube to visualize the urinary tract, medical endoscopy has undergone rapid development. This evolution can be broadly divided into four periods: rigid endoscopy, semi-flexible endoscopy, fiber-optic endoscopy, and the currently widely used electronic video endoscopy. The shape and structure of endoscopes have undergone tremendous changes, and the quality of their imaging has seen successive qualitative improvements.
Due to the late start of China’s endoscopy industry, domestic manufacturers still lag significantly behind their foreign counterparts in the research and development of core technologies and key equipment. Compared with industrial endoscopes, medical endoscopes present higher technical barriers. The medical endoscopy sector in China started relatively late, and its innovation system remains underdeveloped. Consequently, Chinese companies face substantial challenges from foreign enterprises in terms of technology, standards, branding, innovative R&D, and manufacturing capabilities.
Currently, domestic companies are committed to the independent innovation of miniaturized and precision endoscopes, achieving breakthrough progress in key components and core technologies such as precision optical systems and precision mechanical systems for medical endoscopes.
In recent years, driven by a favorable external environment characterized by the rapid overall development of medical devices and strong support from national policies, Chinese medical endoscopy companies have increasingly prioritized independent innovation. This has led to a year-on-year increase in R&D investment and continuous improvements in technological capabilities. Since its establishment, Healnoc has been dedicated to the research and development of endoscopic technologies. To narrow the gap with imported technologies and equipment, Healnoc has continuously intensified its innovation efforts, focusing on product innovation and establishing it as a core component of its long-term development strategy.
In 2020, Healnoc participated in the Autumn CMEF 2020, making its debut with the theme “Beyond Vision, Exceeding Expectations” and showcasing its “True 4K Ultra-HD Endoscopic Camera System,” which was 100% independently developed. Although the pandemic led to a slight decrease in overall attendance at CMEF compared to previous years, Healnoc’s booth remained bustling, rivaling those of established industry leaders. By leveraging its strong R&D capabilities, Healnoc successfully stood out from the competition and garnered interest from over 200 potential partners.
In 2021, Healnoc made another appearance at the CMEF. In addition to its true 4K imaging system, Healnoc showcased a “live silkworm fluorescence demonstration,” which became a standout attraction at the exhibition and drew large crowds of attendees. As Healnoc’s latest breakthrough product, its 4K endoscopic imaging system achieved dual advancements in both the camera head and the image processor, while offering seven key advantages.
Seven Key Advantages of 4K Endoscopic Camera Systems
From May 28 to 30, 2021, Healnoc was invited to participate in the Annual Meeting of the Biliary Surgery Group of the Surgical Branch of the Chinese Medical Association. Healnoc showcased its true 4K camera system at the conference, highlighting its advantages by integrating the theoretical knowledge and clinical experience of two keynote speakers: Yu Hong, Vice President of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, and Gong Wei, Director of the Department of General Surgery at Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.
Recently, Healnoc participated in conferences related to biliary tract diseases, presenting further insights on smart healthcare to advance the precision of biliary disease treatment, and has been actively proposing its recommendations for smart healthcare.
Biliary tract diseases encompass a broad spectrum of conditions with complex clinical presentations. Although there is a large number of practitioners specializing in biliary disorders and significant technical advancements have been made in their diagnosis and treatment, further efforts are needed to standardize clinical concepts. Consensus statements and guidelines should be developed through in-depth research on diagnostic and therapeutic strategies, and clinical research in this field requires more extensive exploration.. As endoscopy serves as a key adjunctive therapy for biliary tract diseases, Healnoc must prioritize this domain, striving to leverage its robust technological capabilities. By focusing on biliary disorders as an entry point, the company aims to extend intelligent healthcare solutions across various medical specialties, thereby contributing to the Healthy China initiative.
Healnoc has been in operation for just two and a half years. In the future, Healnoc will deepen its engagement in the endoscopy field, pursue independent research and development, and drive innovative breakthroughs.